How to Order TRT Online: A Guide to Safe Use

Who Qualifies for Testosterone Replacement Therapy

A TRT prescription requires a confirmed diagnosis of hypogonadism. The 2018 Endocrine Society Clinical Practice Guideline defines this as a total testosterone level below 300 ng/dL on at least two morning fasting blood draws, combined with clinical symptoms such as low libido, erectile dysfunction, fatigue, or loss of lean mass [1].

Not every man with borderline testosterone needs treatment. Symptoms matter as much as the number. A man with a total testosterone of 280 ng/dL and no complaints may not benefit from therapy, while a man at 310 ng/dL with significant sexual dysfunction and fatigue may warrant a trial after secondary causes are excluded. The American Urological Association (AUA) guideline on testosterone deficiency recommends measuring testosterone between 8:00 and 11:00 AM, when levels peak, to avoid false-low readings from normal diurnal variation [2].

Secondary causes of low testosterone should be ruled out before starting therapy. Obstructive sleep apnea, opioid use, hyperprolactinemia, iron overload, and severe obesity can all suppress the hypothalamic-pituitary-gonadal axis. Correcting these conditions sometimes restores testosterone to normal without exogenous hormones. A reputable online TRT clinic will screen for these conditions during the intake process. Any clinic that skips this step is cutting a clinical corner that could harm you.

The prevalence of hypogonadism increases with age. Data from the Massachusetts Male Aging Study found that total testosterone declines by roughly 1.6% per year after age 40 [3]. The Hypogonadism in Males (HIM) study, a cross-sectional analysis of 2,162 men in primary care, reported that 38.7% of men aged 45 and older had total testosterone below 300 ng/dL [4].

How Legitimate Online TRT Clinics Work

The process follows a predictable sequence: lab work, provider consultation, prescription, pharmacy fulfillment, and ongoing monitoring. Each step is required. Skip one and you are not receiving standard-of-care treatment.

Step 1: Lab work. You either visit a local lab (Quest, Labcorp, or a partner draw site) for a morning blood panel, or some clinics accept recent labs completed within 60 to 90 days. The Endocrine Society recommends a minimum panel that includes total testosterone, free testosterone (calculated or equilibrium dialysis), LH, FSH, prolactin, SHBG, CBC with hematocrit, a comprehensive metabolic panel, lipid panel, and PSA for men over 40 [1].

Step 2: Provider consultation. A licensed physician, nurse practitioner, or physician assistant reviews your labs and symptoms via video or phone. Under the Ryan Haight Act, a valid prescriber-patient relationship requires a real-time clinical evaluation before prescribing a controlled substance via telemedicine. The provider should discuss treatment goals, potential side effects, fertility implications, and monitoring intervals.

Step 3: Prescription and fulfillment. If you qualify, the provider sends a prescription to a licensed pharmacy (often a compounding pharmacy for injectable testosterone). Testosterone cypionate and testosterone enanthate are the two most common injectable esters. The medication ships to your door with supplies (syringes, alcohol swabs, sharps container). The FDA lists testosterone as a Schedule III controlled substance, so it must go through a DEA-registered pharmacy [5].

Step 4: Monitoring. Follow-up labs at 6 to 12 weeks after starting therapy confirm that serum testosterone has reached the target range (typically 450 to 700 ng/dL mid-injection), hematocrit remains below 54%, and PSA has not spiked. The AUA guideline recommends reassessment at 3 months, 6 months, and annually thereafter [2].

Red Flags That Signal an Unsafe Online TRT Source

Not all online testosterone providers meet clinical or legal standards. Some warning signs are obvious. Others are subtle.

No lab requirement. If a website offers to ship testosterone based on a symptom questionnaire alone, it is operating outside clinical guidelines and likely outside the law. The Endocrine Society, AUA, and American Association of Clinical Endocrinology (AACE) all require biochemical confirmation of low testosterone before treatment [1][2][6].

No live provider interaction. A pre-recorded video, a chatbot, or an asynchronous message exchange does not meet the Ryan Haight Act's requirement for a real-time prescriber-patient interaction before dispensing a Schedule III substance. "We had someone review your form" is not a clinical evaluation.

Foreign or unregulated pharmacies. Testosterone shipped from overseas pharmacies bypasses FDA quality controls. A 2018 analysis published in JAMA Network Open found that 25% of supplements purchased online contained unlisted anabolic steroids or prohormones [7]. Products from unregulated sources carry contamination, mislabeling, and dosing risks.

Pressure to buy high-dose "optimization" packages. Clinics that push supraphysiologic testosterone doses (above 200 mg per week without clinical justification), routine HCG, anastrozole, and DHEA bundles to every patient regardless of labs are prioritizing revenue over evidence. While some men benefit from adjunct therapies, these should be individualized.

No mention of risks. Legitimate providers discuss erythrocytosis, cardiovascular considerations, fertility suppression, and the FDA's boxed warning requiring disclosure of potential cardiovascular risk [8]. A clinic that only talks about benefits is selling, not treating.

Choosing the Right Testosterone Formulation

The formulation you choose affects dosing frequency, absorption consistency, convenience, and cost. All FDA-approved options achieve therapeutic testosterone levels when dosed correctly. The differences are practical.

Testosterone cypionate injection (100 to 200 mg intramuscularly or subcutaneously every 7 to 14 days) is the most widely prescribed TRT formulation in the U.S. It is inexpensive ($30 to $90 per 10 mL vial without insurance) and produces predictable pharmacokinetics. Peak levels occur 24 to 48 hours post-injection, with a half-life of approximately 8 days [9]. Many men prefer weekly subcutaneous injections with a 27-gauge insulin syringe to reduce peak-trough fluctuations.

Testosterone enanthate has nearly identical pharmacokinetics to cypionate and can be used interchangeably. Cost and availability are similar.

Topical testosterone gel (AndroGel, Testim, Vogelxo) delivers 50 to 100 mg daily through the skin. It maintains steadier serum levels than bi-weekly injections but costs significantly more ($200 to $500 per month without insurance) and carries a transfer risk to household contacts, especially children and women. The FDA's 2009 safety communication warned of virilization in children exposed through skin contact with treated adults [10].

Nasal testosterone gel (Natesto) delivers testosterone three times daily via nasal application. It may preserve spermatogenesis better than injections because its short half-life allows partial recovery of the HPG axis between doses. A 2019 study in the Journal of Urology showed that 90% of men on Natesto maintained sperm concentrations above 10 million/mL at 6 months [11]. The tradeoff is frequency: three applications per day is burdensome.

Testosterone pellets (Testopel) are implanted subcutaneously every 3 to 6 months. They provide the most consistent levels but require an in-office procedure and carry a 5 to 12% extrusion rate.

Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School and author of Testosterone for Life, has noted: "The best testosterone formulation is the one the patient will actually use consistently. Compliance drives outcomes more than the delivery method" [12].

What Your First 90 Days on TRT Should Look Like

The first three months set the trajectory for long-term success. Expect a structured protocol, not a set-it-and-forget-it prescription.

Weeks 1 to 4: Most men notice improved energy, mood, and sleep quality within two to three weeks. Libido improvements may take four to six weeks. Body composition changes (reduced fat mass, increased lean mass) require eight to twelve weeks at minimum. A 2016 meta-analysis in Medicine pooling 37 RCTs (N=3,290) found that TRT reduced fat mass by a mean of 1.6 kg and increased lean mass by 1.6 kg over 12 months compared to placebo [13].

Weeks 4 to 6: Some men experience acne, oily skin, or mild fluid retention as androgen receptors upregulate. These effects are typically transient. If nipple sensitivity or gynecomastia symptoms appear, contact your provider. Estradiol may need to be checked, though routine aromatase inhibitor use is not recommended by the Endocrine Society for most men on standard TRT doses [1].

Week 8 to 12 (Follow-up labs): Your provider should order total testosterone (drawn at the trough, just before your next injection), free testosterone, estradiol (sensitive assay), CBC with hematocrit, PSA, and a liver panel. This follow-up determines whether your dose needs adjustment. The target trough testosterone is typically 400 to 700 ng/dL. Hematocrit above 54% requires dose reduction, injection frequency adjustment, or therapeutic phlebotomy per Endocrine Society guidelines [1].

Dr. Shalender Bhasin, Professor of Medicine at Harvard Medical School and principal investigator of the Testosterone Trials (TTrials), has stated: "Testosterone treatment should be viewed as a long-term commitment with structured monitoring, not a quick intervention. The men who do best are the ones whose clinicians adjust the dose based on both symptoms and laboratory values" [14].

Cardiovascular Safety: What the Evidence Actually Shows

Cardiovascular risk has been the most debated topic in TRT for over a decade. The evidence has shifted significantly since early observational concerns.

The TRAVERSE trial (Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy Response in Hypogonadal Men), published in the New England Journal of Medicine in 2023, was a randomized, double-blind, placebo-controlled cardiovascular safety trial enrolling 5,246 men aged 45 to 80 with hypogonadism and established or high risk for cardiovascular disease. After a mean follow-up of 33 months, the incidence of major adverse cardiovascular events (MACE) was 7.0% in the testosterone group versus 7.3% in the placebo group (hazard ratio 0.96 to 95% CI 0.78 to 1.17) [15]. Testosterone did not increase cardiovascular risk.

This was a large, definitive trial. It was designed specifically to address the FDA's 2015 requirement for post-marketing cardiovascular safety data. The results do not suggest that TRT is cardioprotective, but they do demonstrate that it is not the cardiovascular hazard that earlier, smaller, methodologically limited studies suggested.

One caveat remains. TRAVERSE confirmed a modest but statistically significant increase in venous thromboembolism: pulmonary embolism occurred in 0.9% of the testosterone group versus 0.5% of the placebo group [15]. This aligns with the known erythrocytosis effect of testosterone. Men with a history of VTE or known thrombophilia should discuss this risk with their prescriber before starting therapy.

The FDA's current labeling still includes cardiovascular and VTE warnings, though the agency has not updated its language to reflect the TRAVERSE data as of early 2026 [8].

Fertility Considerations Before Starting TRT

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis. LH and FSH levels drop. Sperm production decreases, often to azoospermia. This effect is dose-dependent and usually reversible, but recovery can take 6 to 18 months after discontinuation, and full recovery is not guaranteed for all men.

The Endocrine Society guideline explicitly states: "We recommend against testosterone therapy in men who are currently trying to conceive" [1]. Men who want to preserve fertility while treating low testosterone have several options.

Clomiphene citrate (25 to 50 mg daily or every other day, off-label) is a selective estrogen receptor modulator that blocks negative feedback at the hypothalamus, increasing LH and FSH secretion and thereby stimulating both endogenous testosterone production and spermatogenesis. A 2015 retrospective study in BJU International reported that clomiphene raised testosterone from a mean of 228 ng/dL to 612 ng/dL while maintaining sperm parameters in hypogonadal men [16].

Enclomiphene, the trans-isomer of clomiphene, is under investigation and may offer similar efficacy with fewer estrogenic side effects, though it is not yet FDA-approved for this indication.

Human chorionic gonadotropin (HCG) (500 to 1 to 500 IU two to three times per week) can be used alone or alongside TRT to maintain intratesticular testosterone and preserve spermatogenesis. Some online TRT clinics include HCG as part of their protocol specifically for younger men or those considering future paternity.

If you are under 40 or have any interest in fathering children, raise this topic during your first consultation. A provider who does not ask about fertility goals is missing a critical part of the intake.

How Much Does Online TRT Actually Cost

Cost varies by clinic, formulation, and whether insurance is used. Most men pay out-of-pocket for online TRT because many insurance plans require prior authorization, step therapy, or restrict coverage to specific diagnoses.

Typical monthly costs at established online TRT clinics range from $99 to $250 per month. This usually includes the provider consultation, ongoing monitoring, and medication. Testosterone cypionate itself is among the least expensive prescription medications in the U.S. A 10 mL vial of 200 mg/mL testosterone cypionate costs $30 to $90 at retail pharmacies with a GoodRx coupon. The premium at online clinics covers the clinical infrastructure: labs, provider time, and care coordination.

Lab work adds additional cost. Initial panels run $100 to $300 if ordered through the clinic's lab partner. Follow-up panels (every 3 to 6 months in the first year) are typically $75 to $150 each. Some clinics bundle lab costs into their monthly fee. Others bill separately. Ask before signing up.

Compare total annual cost, not monthly price alone. A clinic advertising $99 per month that charges $250 per lab panel and requires quarterly labs costs $1,188 plus $1 to 000 in labs, totaling $2,188 per year. A clinic charging $199 per month with labs included costs $2,388 per year. The difference is smaller than the sticker price suggests.

Ongoing Monitoring: The Non-Negotiable Part

TRT without monitoring is not treatment. It is self-medication with a prescription.

The Endocrine Society recommends the following monitoring schedule [1]:

• 3 months: Total testosterone, hematocrit, PSA (men over 40), symptom reassessment.
• 6 months: Repeat of the above panel.
• Annually thereafter: Total testosterone, hematocrit, PSA, lipid panel, comprehensive metabolic panel, symptom assessment.
• Bone mineral density (DXA): After 1 to 2 years of therapy in men with osteoporosis or osteopenia at baseline.

Hematocrit is the single most important safety lab on TRT. Testosterone stimulates erythropoiesis through EPO upregulation and direct marrow stimulation. Hematocrit above 54% increases blood viscosity and the risk of thromboembolic events. The TRAVERSE trial reported that polycythemia (hematocrit >54%) occurred in 22.5% of men in the testosterone group versus 1.6% in the placebo group [15]. This is a manageable side effect, but only if it is being measured.

PSA monitoring is standard for men over 40. TRT does not cause prostate cancer based on available evidence, but it may unmask occult disease by stimulating growth of existing microfoci. A PSA rise of more than 1.4 ng/mL within the first 12 months, or an absolute value above 4.0 ng/mL, warrants urological referral per AUA guidelines [2].

If your online TRT provider does not order follow-up labs or does not review them with you, find a different provider.